Celine Bourdon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Celine Bourdon has a total of 246 co-authors. Here are the top co-authors by number of shared publications:
- Robert H. J. Bandsma
University of Toronto
19 shared publications - Wieger Voskuijl
Amsterdam UMC, location University of Amsterdam, Amsterdam Centre for Global Child Health Emma Children's hospital Amsterdam the Netherlands
12 shared publications - James Alexander Berkley
The Childhood Acute Illness & Nutrition Network, Nairobi, Kenya
9 shared publications - Isabel Potani
The Childhood Acute Illness & Nutrition Network, Nairobi, Kenya
7 shared publications - Allison I. Daniel
Consultant to the World Health Organization, Geneva, Switzerland
5 shared publications - Emmanuel Chimwezi
The Childhood Acute Illness and Nutrition (CHAIN) Network, Nairobi, Kenya
5 shared publications
Latest Publications
- Open Access
- 15 August 2026
- Published by Elsevier in eClinicalMedicine
- Vol. 99, 104110
Pancreatic enzymes and bile acids alone and in combination for acutely ill, severely malnourished children: a multi-country double-blind randomised placebo-controlled trial
- 15 August 2026
- Published by Elsevier in eClinicalMedicine
- Vol. 99, 104110
Open AccessPancreatic enzymes and bile acids alone and in combination for acutely ill, severely malnourished children: a multi-country double-blind randomised placebo-controlled trial
- Open Access
- 28 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 10788
Inflammation impairs post-hospital discharge growth among children hospitalised with acute illness in sub-Saharan Africa and south Asia
In resource-limited settings, children often experience poor growth following illness, but the mechanisms are poorly understood. This cohort study in six countries in sub-Saharan Africa and south Asia investigates pathways linking inflammation and post-discharge weight gain among children hospitalised with acute illness. We determine associations between inflammation, enteropathy, growth mediators and other exposures at hospital discharge and weight gain during 90 days and explain how these exposures influence growth. Here, we show that systemic inflammation impacts mediators of linear growth including the Growth hormone/Insulin-like growth factor 1 axis and bone metabolism to a larger extent and weight gain via enteroendocrine peptide YY and glucagon pathways to a lesser extent. Systemic inflammation negatively affects weight gain directly. Enteropathy impacts growth through systemic inflammation. Adverse household and chronic medical conditions predominantly influence weight gain through inflammation. It is critical to address inflammation, the intestinal mucosal barrier and other exposures driving inflammation to optimise recovery.
- 28 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 10788
Open AccessInflammation impairs post-hospital discharge growth among children hospitalised with acute illness in sub-Saharan Africa and south Asia
In resource-limited settings, children often experience poor growth following illness, but the mechanisms are poorly understood. This cohort study in six countries in sub-Saharan Africa and south Asia investigates pathways linking inflammation and post-discharge weight gain among children hospitalised with acute illness. We determine associations between inflammation, enteropathy, growth mediators and other exposures at hospital discharge and weight gain during 90 days and explain how these exposures influence growth. Here, we show that systemic inflammation impacts mediators of linear growth including the Growth hormone/Insulin-like growth factor 1 axis and bone metabolism to a larger extent and weight gain via enteroendocrine peptide YY and glucagon pathways to a lesser extent. Systemic inflammation negatively affects weight gain directly. Enteropathy impacts growth through systemic inflammation. Adverse household and chronic medical conditions predominantly influence weight gain through inflammation. It is critical to address inflammation, the intestinal mucosal barrier and other exposures driving inflammation to optimise recovery.
- Open Access
- 18 August 2025
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 12 (9) , ofaf487
Antimicrobial Usage Among Acutely Ill Hospitalized Children Aged 2‒23 Months in Sub-Saharan Africa and South Asia
Background: Understanding patterns of antimicrobial use is critical to supporting antibiotic stewardship and limiting antimicrobial resistance (AMR). We aimed to describe antimicrobial prescribing in acutely ill hospitalized children aged 2–23 months across a range of rural and urban hospital settings in Sub-Saharan Africa and South Asia. Methods: The Childhood Acute Illness & Nutrition (CHAIN) cohort collected data daily throughout hospitalization from children with acute illness aged 2–23 months admitted to 9 hospitals from November 2016 to January 2019. We determined proportions of children receiving antimicrobials, inpatient-days receiving antimicrobials, antimicrobial classes, World Health Organization (WHO) Access, Watch, and Reserve (AWaRe) classifications, and examined factors associated with Watch antimicrobial use. Results: Of 3101 admissions, 1422 (46%) received antimicrobials before hospitalization. A total of 2816 (91%) children received antimicrobials during 19 398/21 807 (93%) inpatient child-days. Two thousand four hundred seventy-seven (76%), 1092 (35%), and 12 (0.3%) children received Access, Watch, and Reserve antimicrobials, mostly within 48 hours of admission. Three hundred forty-one (11%) admissions received an antimicrobial without any indication. Prior admission, chronic illness, diagnoses of sepsis or meningitis, hypoglycemia, and duration of admission were associated with receiving Watch antimicrobials, while WHO danger signs, severe malnutrition, HIV, and receipt of prior antimicrobials were not, despite their known association with mortality and AMR. Conclusions: Antimicrobial use was similar across sites, with some overuse and notably limited escalation and de-escalation, likely due to guideline adherence. Guidelines need updating for the absence of relevant antimicrobial sensitivities, to include risk-based antimicrobial prescribing considering mortality risk and prior exposure to antimicrobials and the hospital environment. Hence, clinical trials of risk-differentiated care are needed.
- 18 August 2025
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 12 (9) , ofaf487
Open AccessAntimicrobial Usage Among Acutely Ill Hospitalized Children Aged 2‒23 Months in Sub-Saharan Africa and South Asia
Background: Understanding patterns of antimicrobial use is critical to supporting antibiotic stewardship and limiting antimicrobial resistance (AMR). We aimed to describe antimicrobial prescribing in acutely ill hospitalized children aged 2–23 months across a range of rural and urban hospital settings in Sub-Saharan Africa and South Asia. Methods: The Childhood Acute Illness & Nutrition (CHAIN) cohort collected data daily throughout hospitalization from children with acute illness aged 2–23 months admitted to 9 hospitals from November 2016 to January 2019. We determined proportions of children receiving antimicrobials, inpatient-days receiving antimicrobials, antimicrobial classes, World Health Organization (WHO) Access, Watch, and Reserve (AWaRe) classifications, and examined factors associated with Watch antimicrobial use. Results: Of 3101 admissions, 1422 (46%) received antimicrobials before hospitalization. A total of 2816 (91%) children received antimicrobials during 19 398/21 807 (93%) inpatient child-days. Two thousand four hundred seventy-seven (76%), 1092 (35%), and 12 (0.3%) children received Access, Watch, and Reserve antimicrobials, mostly within 48 hours of admission. Three hundred forty-one (11%) admissions received an antimicrobial without any indication. Prior admission, chronic illness, diagnoses of sepsis or meningitis, hypoglycemia, and duration of admission were associated with receiving Watch antimicrobials, while WHO danger signs, severe malnutrition, HIV, and receipt of prior antimicrobials were not, despite their known association with mortality and AMR. Conclusions: Antimicrobial use was similar across sites, with some overuse and notably limited escalation and de-escalation, likely due to guideline adherence. Guidelines need updating for the absence of relevant antimicrobial sensitivities, to include risk-based antimicrobial prescribing considering mortality risk and prior exposure to antimicrobials and the hospital environment. Hence, clinical trials of risk-differentiated care are needed.
- Open Access
- 21 March 2025
- Published by Springer Nature in Research Square
Inflammation impairs post-hospital discharge growth among children hospitalised with acute illness in sub-Saharan Africa and south Asia
Childhood growth can be affected by acute illness, chronic conditions, diet and their home environment. In resource-poor settings, children often experience poor growth following illness, but the mechanisms are poorly understood. This cohort study nested within the CHAIN cohort in six countries in sub-Saharan Africa and south Asia investigated pathways linking inflammation and post-discharge weight gain among children hospitalised with acute illness. We analysed biomarkers of inflammation, enteropathy, growth mediators and other exposures at hospital discharge and examined how they impact post-discharge weight gain during 90 days. Linear mixed models determined associations between exposures and weight gain while structural equation models explained how these exposures influence growth. We show that systemic inflammation impacts mediators of linear growth including the GH/IGF1 axis and bone metabolism to a larger extent and weight gain via enteroendocrine peptide YY and glucagon pathways to a lesser extent. Systemic inflammation negatively affects weight gain directly. Intestinal dysfunction impacts growth through systemic inflammation. Adverse household and chronic medical conditions predominantly influenced weight gain through inflammation. Persistent systemic inflammation at hospital discharge strongly impairs post-discharge linear growth and limits weight gain. It is critical to address inflammation, the intestinal mucosal barrier and other exposures driving inflammation to optimise recovery. One Sentence Summary: Inflammation driven by illness, enteropathy and adverse social factors redirects post-hospital recovery away from linear growth and limits weight gain.
- 21 March 2025
- Published by Springer Nature in Research Square
Open AccessInflammation impairs post-hospital discharge growth among children hospitalised with acute illness in sub-Saharan Africa and south Asia
Childhood growth can be affected by acute illness, chronic conditions, diet and their home environment. In resource-poor settings, children often experience poor growth following illness, but the mechanisms are poorly understood. This cohort study nested within the CHAIN cohort in six countries in sub-Saharan Africa and south Asia investigated pathways linking inflammation and post-discharge weight gain among children hospitalised with acute illness. We analysed biomarkers of inflammation, enteropathy, growth mediators and other exposures at hospital discharge and examined how they impact post-discharge weight gain during 90 days. Linear mixed models determined associations between exposures and weight gain while structural equation models explained how these exposures influence growth. We show that systemic inflammation impacts mediators of linear growth including the GH/IGF1 axis and bone metabolism to a larger extent and weight gain via enteroendocrine peptide YY and glucagon pathways to a lesser extent. Systemic inflammation negatively affects weight gain directly. Intestinal dysfunction impacts growth through systemic inflammation. Adverse household and chronic medical conditions predominantly influenced weight gain through inflammation. Persistent systemic inflammation at hospital discharge strongly impairs post-discharge linear growth and limits weight gain. It is critical to address inflammation, the intestinal mucosal barrier and other exposures driving inflammation to optimise recovery. One Sentence Summary: Inflammation driven by illness, enteropathy and adverse social factors redirects post-hospital recovery away from linear growth and limits weight gain.
- Open Access
- 1 February 2025
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 9 (2)
Children with autoimmune hepatitis receiving standard-of-care therapy demonstrate long-term obesity and linear growth delay
Background: Standard-of-care therapy in children with autoimmune hepatitis (AIH) includes induction with prednisone 1–2 mg/kg daily with gradual weaning of the dose. We aimed to test the hypothesis that children with AIH receiving standard-of-care treatment have altered growth trajectories. Methods: Children diagnosed with AIH between 1997 and 2023 at SickKids had serial growth measurements. Mixed effect models assessed the impact of time and daily steroid exposure on z -scores. Kaplan-Meier survival methods were used to estimate the cumulative incidence of new-onset growth impairments. A time-dependent Cox proportional hazards model was constructed to determine predictors for growth impairments. Results: Sixty-one children (66% females, median age at diagnosis 11.5 y) were included. BMIz showed a sharp increase, and HAZ declined significantly without returning to baseline. Each 1 mg/kg/d prednisone exposure increased BMIz gain in the first 6 months by 0.27 ([95% CI: 0.11, 0.42], p = 0.001), and decreased HAZ by −0.02 ([95% CI: −0.03, −0.01], p = 0.005). Children diagnosed before puberty exhibited a higher occurrence of excessive weight gain (72.2% vs. 49.3%; log-rank p < 0.01) and obesity (63% vs. 31.5%; log-rank p < 0.01) compared to those diagnosed during puberty. In a Cox proportional-hazards model, young age at diagnosis and daily prednisone dose >10 mg 6 months after diagnosis were predictors for linear growth delay. Conclusions: This study demonstrates that children with AIH receiving standard-of-care therapy demonstrate altered growth trajectories, long-term excess weight gain, obesity, and linear growth delay. Young age at diagnosis and >10 mg of daily prednisone at 6 months are predictors for linear growth delay. These data indicate the need to re-evaluate standard treatment algorithms for pediatric AIH in terms of steroid dosing and potential nonsteroid alternatives.
- 1 February 2025
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 9 (2)
Open AccessChildren with autoimmune hepatitis receiving standard-of-care therapy demonstrate long-term obesity and linear growth delay
Background: Standard-of-care therapy in children with autoimmune hepatitis (AIH) includes induction with prednisone 1–2 mg/kg daily with gradual weaning of the dose. We aimed to test the hypothesis that children with AIH receiving standard-of-care treatment have altered growth trajectories. Methods: Children diagnosed with AIH between 1997 and 2023 at SickKids had serial growth measurements. Mixed effect models assessed the impact of time and daily steroid exposure on z -scores. Kaplan-Meier survival methods were used to estimate the cumulative incidence of new-onset growth impairments. A time-dependent Cox proportional hazards model was constructed to determine predictors for growth impairments. Results: Sixty-one children (66% females, median age at diagnosis 11.5 y) were included. BMIz showed a sharp increase, and HAZ declined significantly without returning to baseline. Each 1 mg/kg/d prednisone exposure increased BMIz gain in the first 6 months by 0.27 ([95% CI: 0.11, 0.42], p = 0.001), and decreased HAZ by −0.02 ([95% CI: −0.03, −0.01], p = 0.005). Children diagnosed before puberty exhibited a higher occurrence of excessive weight gain (72.2% vs. 49.3%; log-rank p < 0.01) and obesity (63% vs. 31.5%; log-rank p < 0.01) compared to those diagnosed during puberty. In a Cox proportional-hazards model, young age at diagnosis and daily prednisone dose >10 mg 6 months after diagnosis were predictors for linear growth delay. Conclusions: This study demonstrates that children with AIH receiving standard-of-care therapy demonstrate altered growth trajectories, long-term excess weight gain, obesity, and linear growth delay. Young age at diagnosis and >10 mg of daily prednisone at 6 months are predictors for linear growth delay. These data indicate the need to re-evaluate standard treatment algorithms for pediatric AIH in terms of steroid dosing and potential nonsteroid alternatives.
- Open Access
- 26 December 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (12) , e0311534
Ten-year trends in clinical characteristics and outcome of children hospitalized with severe wasting or nutritional edema in Malawi (2011–2021): Declining admissions but worsened clinical profiles
Background: Severe acute malnutrition (SAM) constitutes a substantial burden in African hospitals. Despite adhering to international guidelines, high inpatient mortality rates persist and the underlying contributing factors remain poorly understood. Objective: We evaluated the 10-year trend (2011–2021) in clinical factors and outcomes among children with severe wasting and/or nutritional edema at Malawi’s largest nutritional rehabilitation unit (NRU). Methods: This retrospective study analyzed trends in presentation and outcomes using generalized additive models. The association between clinical characteristics and mortality or readmission was examined and key features were also related to time to either mortality or discharge. Results: 1497 children (53%, females) were included. Median age at admission (23 months, IQR 14, 34) or anthropometry (i.e., weight-for-age, height-for-age and weight-for-height) did not change over the 10-years. But the prevalence of edema decreased by 40% whereas dehydration, difficulty breathing, and pallor became more common. Yearly HIV testing increased but positive-detection remained around 11%. Reporting of complete vaccination dropped by 49%, and no reduction in ‘watch’ antibiotic usage was detected. Overall admissions declined but mortality remained around 23% [95%CI; 21, 25], and deaths occurred earlier (5.6 days [95%CI; 4.6, 6.9] in 2011 vs. 3.5 days [95%CI; 2.5, 4.7] in 2021; pp<0.001). Age, wasting, having both dehydration and diarrhea, or having vomiting, cough, or difficulty breathing were associated with mortality but these associations did not show any interaction over time. Conclusion: Over 10 years, mortality risk remained high among hospitalized children with SAM and coincided with worsened clinical presentation at admission and increased readmission. Longitudinal data from major NRUs can identify shifts in clinical profiles or outcomes, and this information can be leveraged to promote earlier care-seeking, improved risk stratification, and implementation of more patient-centered treatments.
- 26 December 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (12) , e0311534
Open AccessTen-year trends in clinical characteristics and outcome of children hospitalized with severe wasting or nutritional edema in Malawi (2011–2021): Declining admissions but worsened clinical profiles
Background: Severe acute malnutrition (SAM) constitutes a substantial burden in African hospitals. Despite adhering to international guidelines, high inpatient mortality rates persist and the underlying contributing factors remain poorly understood. Objective: We evaluated the 10-year trend (2011–2021) in clinical factors and outcomes among children with severe wasting and/or nutritional edema at Malawi’s largest nutritional rehabilitation unit (NRU). Methods: This retrospective study analyzed trends in presentation and outcomes using generalized additive models. The association between clinical characteristics and mortality or readmission was examined and key features were also related to time to either mortality or discharge. Results: 1497 children (53%, females) were included. Median age at admission (23 months, IQR 14, 34) or anthropometry (i.e., weight-for-age, height-for-age and weight-for-height) did not change over the 10-years. But the prevalence of edema decreased by 40% whereas dehydration, difficulty breathing, and pallor became more common. Yearly HIV testing increased but positive-detection remained around 11%. Reporting of complete vaccination dropped by 49%, and no reduction in ‘watch’ antibiotic usage was detected. Overall admissions declined but mortality remained around 23% [95%CI; 21, 25], and deaths occurred earlier (5.6 days [95%CI; 4.6, 6.9] in 2011 vs. 3.5 days [95%CI; 2.5, 4.7] in 2021; pp<0.001). Age, wasting, having both dehydration and diarrhea, or having vomiting, cough, or difficulty breathing were associated with mortality but these associations did not show any interaction over time. Conclusion: Over 10 years, mortality risk remained high among hospitalized children with SAM and coincided with worsened clinical presentation at admission and increased readmission. Longitudinal data from major NRUs can identify shifts in clinical profiles or outcomes, and this information can be leveraged to promote earlier care-seeking, improved risk stratification, and implementation of more patient-centered treatments.
- Open Access
- 12 March 2024
- Published by Elsevier in eClinicalMedicine
- Vol. 70, 102530
Childhood growth during recovery from acute illness in Africa and South Asia: a secondary analysis of the childhood acute illness and nutrition (CHAIN) prospective cohort
- 12 March 2024
- Published by Elsevier in eClinicalMedicine
- Vol. 70, 102530
Open AccessChildhood growth during recovery from acute illness in Africa and South Asia: a secondary analysis of the childhood acute illness and nutrition (CHAIN) prospective cohort
- Open Access
- 13 February 2024
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 83 (1) , 112-145
Micronutrient status in children aged 6–59 months with severe wasting and/or nutritional edema: implications for nutritional rehabilitation formulations
Undernutrition remains a global struggle and is associated with almost 45% of deaths in children younger than 5 years. Despite advances in management of severe wasting (though less so for nutritional edema), full and sustained recovery remains elusive. Children with severe wasting and/or nutritional edema (also commonly referred to as severe acute malnutrition and part of the umbrella term “severe malnutrition”) continue to have a high mortality rate. This suggests a likely multifactorial etiology that may include micronutrient deficiency. Micronutrients are currently provided in therapeutic foods at levels based on expert opinion, with few supportive studies of high quality having been conducted. This narrative review looks at the knowledge base on micronutrient deficiencies in children aged 6–59 months who have severe wasting and/or nutritional edema, in addition to highlighting areas where further research is warranted (See “Future Directions” section).
- 13 February 2024
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 83 (1) , 112-145
Open AccessMicronutrient status in children aged 6–59 months with severe wasting and/or nutritional edema: implications for nutritional rehabilitation formulations
Undernutrition remains a global struggle and is associated with almost 45% of deaths in children younger than 5 years. Despite advances in management of severe wasting (though less so for nutritional edema), full and sustained recovery remains elusive. Children with severe wasting and/or nutritional edema (also commonly referred to as severe acute malnutrition and part of the umbrella term “severe malnutrition”) continue to have a high mortality rate. This suggests a likely multifactorial etiology that may include micronutrient deficiency. Micronutrients are currently provided in therapeutic foods at levels based on expert opinion, with few supportive studies of high quality having been conducted. This narrative review looks at the knowledge base on micronutrient deficiencies in children aged 6–59 months who have severe wasting and/or nutritional edema, in addition to highlighting areas where further research is warranted (See “Future Directions” section).
- Open Access
Childhood growth trajectory patterns are associated with the pubertal gut microbiota
The relationship between growth and gut microbiota establishment is critical but under-investigated during late childhood. This is an important knowledge gap since the adult microbiota connects with other organs to influence health. We studied gut microbial communities composition and dietary patterns in 13 years old males and females from the 2004 Pelotas birth cohort (Brazil). We had previously shown that three BMIZ and HAZ patterns of growth since birth are present in this cohort, reflecting the nutritional status of these children. Here, we show that there is an association between growth patterns and gut microbiota, which encompasses the five pubertal stages, and which is affected by sex. Using Partial Least Square Path Modelling, we also show that there is a strong relationship between dietary patterns and gut microbiota, in males but not females. These data provide the microbiota and dietary profiles of highly phenotyped children and highlight the importance of childhood growth and sex for the maturation of the gut microbiota and long-term healthy growth. The role of pubertal diet in the relationships identified, further underlies the importance of dietary patterns establishment during adolescence while providing an opportunity for late modification of growth-microbiota relationships.
Open AccessChildhood growth trajectory patterns are associated with the pubertal gut microbiota
The relationship between growth and gut microbiota establishment is critical but under-investigated during late childhood. This is an important knowledge gap since the adult microbiota connects with other organs to influence health. We studied gut microbial communities composition and dietary patterns in 13 years old males and females from the 2004 Pelotas birth cohort (Brazil). We had previously shown that three BMIZ and HAZ patterns of growth since birth are present in this cohort, reflecting the nutritional status of these children. Here, we show that there is an association between growth patterns and gut microbiota, which encompasses the five pubertal stages, and which is affected by sex. Using Partial Least Square Path Modelling, we also show that there is a strong relationship between dietary patterns and gut microbiota, in males but not females. These data provide the microbiota and dietary profiles of highly phenotyped children and highlight the importance of childhood growth and sex for the maturation of the gut microbiota and long-term healthy growth. The role of pubertal diet in the relationships identified, further underlies the importance of dietary patterns establishment during adolescence while providing an opportunity for late modification of growth-microbiota relationships.
- Open Access
- 18 February 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (7) , eabj6779
Systemic inflammation and metabolic disturbances underlie inpatient mortality among ill children with severe malnutrition
Children admitted to hospital with an acute illness and concurrent severe malnutrition [complicated severe malnutrition (CSM)] have a high risk of dying. The biological processes underlying their mortality are poorly understood. In this case-control study nested within a multicenter randomized controlled trial among children with CSM in Kenya and Malawi, we found that blood metabolomic and proteomic profiles robustly differentiated children who died (n= 92) from those who survived (n= 92). Fatalities were characterized by increased energetic substrates (tricarboxylic acid cycle metabolites), microbial metabolites (e.g., propionate and isobutyrate), acute phase proteins (e.g., calprotectin and C-reactive protein), and inflammatory markers (e.g., interleukin-8 and tumor necrosis factor–α). These perturbations indicated disruptions in mitochondria-related bioenergetic pathways and sepsis-like responses. This study identified specific biomolecular disturbances associated with CSM mortality, revealing that systemic inflammation and bioenergetic deficits are targetable pathophysiological processes for improving survival of this vulnerable population.
- 18 February 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (7) , eabj6779
Open AccessSystemic inflammation and metabolic disturbances underlie inpatient mortality among ill children with severe malnutrition
Children admitted to hospital with an acute illness and concurrent severe malnutrition [complicated severe malnutrition (CSM)] have a high risk of dying. The biological processes underlying their mortality are poorly understood. In this case-control study nested within a multicenter randomized controlled trial among children with CSM in Kenya and Malawi, we found that blood metabolomic and proteomic profiles robustly differentiated children who died (n= 92) from those who survived (n= 92). Fatalities were characterized by increased energetic substrates (tricarboxylic acid cycle metabolites), microbial metabolites (e.g., propionate and isobutyrate), acute phase proteins (e.g., calprotectin and C-reactive protein), and inflammatory markers (e.g., interleukin-8 and tumor necrosis factor–α). These perturbations indicated disruptions in mitochondria-related bioenergetic pathways and sepsis-like responses. This study identified specific biomolecular disturbances associated with CSM mortality, revealing that systemic inflammation and bioenergetic deficits are targetable pathophysiological processes for improving survival of this vulnerable population.